Brentuximab Vedotin for Steroid Refractory GvHD
NCT01596218
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Graft vs. Host Disease
Interventions
DRUG:
Brentuximab Vedotin
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]
[object Object]